Zobrazeno 1 - 10
of 210
pro vyhledávání: '"Shuhua Han"'
Autor:
Zhixiao Sun, Jian Sun, Hang Hu, Shuhua Han, Panpan Ma, Bingqing Zuo, Zheng Wang, Zhongxiang Liu
Publikováno v:
Heliyon, Vol 10, Iss 9, Pp e30646- (2024)
Background: Lung adenocarcinoma is one of the leading causes of cancer-related deaths because of the lack of early specific clinical indicators. MicroRNAs (miRNAs) have become the focus in lung cancer diagnosis. Further studies are required to explor
Externí odkaz:
https://doaj.org/article/7344c587d84949dd8a27655cc1c6f8e1
Autor:
Jing Huang, Ming Ding, Yuan Lu, Lu Xu, Yu Zhang, Shuhua Han, Xiaoli Zhu, Yiping Li, Pingsheng Chen
Publikováno v:
Cell Death and Disease, Vol 14, Iss 12, Pp 1-11 (2023)
Abstract With the widespread development of chest computed tomography (CT), the detection rate of pulmonary nodules has increased; therefore, the classification of benign vs. malignant nodules has become a common problem in the clinic. MicroRNA, a po
Externí odkaz:
https://doaj.org/article/cdeaf7aa788d467dbecc201ec3ad0230
Publikováno v:
Respiratory Medicine Case Reports, Vol 48, Iss , Pp 101953- (2024)
The availability of targeted therapies for molecular aberrations have substantially improved the outcomes of advanced non-small-cell lung cancer (NSCLC) patients harboring sensitive mutations. However, patients harboring uncommon epidermal growth fac
Externí odkaz:
https://doaj.org/article/aee6ad8bab2547aba999dfce7d3acc01
Publikováno v:
Canadian Respiratory Journal, Vol 2024 (2024)
Background. Anlotinib is an effective targeted therapy for advanced non-small-cell lung cancer (NSCLC) and has been found to mediate chemoresistance in many cancers. However, the underlying molecular mechanism of anlotinib mediates cisplatin (DDP) re
Externí odkaz:
https://doaj.org/article/efcb94f412d24ef9896c913d6d9f4219
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/6ff817e3050049efa05b5320be29b6cc
Autor:
Fei Peng, Qinglin Du, Tiantian Zhou, Yiqi Cao, Xueyan Yang, Fei Hu, Yongcong Tan, Qian Ding, Shuhua Han
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/e088e38d32684e2e8fb6fbd6d17ccba8
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-10 (2023)
Abstract The reliable predictive markers to identify which patients with advanced non-small cell lung cancer tumors (NSCLC) will achieve durable clinical benefit (DCB) for chemo-immunotherapy are needed. In this retrospective study, we collected radi
Externí odkaz:
https://doaj.org/article/366a6a63af6748638c262e715e11132b
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-7 (2022)
Abstract The optimal systemic treatment of advanced large cell neuroendocrine carcinoma (LCNEC) is still controversial. We intend to explore advanced LCNEC through SEER database, construct nomogram model of advanced LCNEC, and understand the effect o
Externí odkaz:
https://doaj.org/article/0eb694c6e3ca44cca0d36fb2f0441f52
Autor:
Zhi Li, Shuhua Han
Publikováno v:
ACS Omega, Vol 7, Iss 26, Pp 22613-22625 (2022)
Externí odkaz:
https://doaj.org/article/2756db7921a349ff9107ae6a73b6368c
Autor:
Junhan Xie, Ziyu Wang, Ruixue Zhu, Jiaming Jiang, Tsu-Chien Weng, Yi Ren, Shuhua Han, Yifan Huang, Weimin Liu
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 11, p 9438 (2023)
The bis-benzimidazole derivative (BBM) molecule, consisting of two 2-(2′-hydroxyphenyl) benzimidazole (HBI) halves, has been synthesized and successfully utilized as a ratiometric fluorescence sensor for the sensitive detection of Cu2+ based on eno
Externí odkaz:
https://doaj.org/article/ed9818becff0440c9d4bb3bb712a3b9f